We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

Back to rankings

61 hedge funds and large institutions have $278M invested in Syneron Medical Ltd in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 71 → 61 (-10)

16% less capital invested

Capital invested by funds: $331M → $278M (-$52.8M)

35% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 23

67% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 15

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
61
Holders Change
-10
Holders Change %
-14.08%
% of All Funds
1.75%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
15
Reduced
23
Closed
15
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$24K

Top Buyers

Rank Fund Capital Flow
1
NTC
North Tide Capital
Massachusetts
+$5.83M
2
BIP
Brandes Investment Partners
California
+$5.43M
3
HC
Hourglass Capital
Texas
+$2.95M
4
Norges Bank
Norges Bank
Norway
+$2.47M
5
HM
HealthCor Management
New York
+$1.16M

Top Sellers

Rank Fund Capital Flow
1
CAD
Craig A. Drill
-$2.36M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.78M
3
EIM
Essex Investment Management
Massachusetts
-$1.35M
4
PIM
Profit Investment Management
Maryland
-$1.25M
5
Renaissance Technologies
Renaissance Technologies
New York
-$786K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$1.02M – – –
PIM
27
Platinum Investment Management
Australia
$973K – – –
DCM
28
DAFNA Capital Management
California
$939K – – –
Two Sigma Investments
29
Two Sigma Investments
New York
$808K -$245K -22,661 -22%
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$687K -$18.1K -1,678 -2%
Citadel Advisors
31
Citadel Advisors
Florida
$634K +$59.2K +5,477 +10%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$583K -$80K -7,400 -12%
TC
33
TFS Capital
Pennsylvania
$500K -$291K -26,894 -36%
MC
34
Moors & Cabot
Massachusetts
$456K -$10.8K -1,000 -2%
Nomura Holdings
35
Nomura Holdings
Japan
$393K -$16.1K -1,494 -4%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$357K – – –
GI
37
GAMCO Investors
Connecticut
$248K – – –
IAM
38
Iridian Asset Management
Connecticut
$213K -$92K -8,510 -29%
Morgan Stanley
39
Morgan Stanley
New York
$177K +$9.41K +871 +5%
BG
40
BlackRock Group
United Kingdom
$171K +$179K +16,547 New
State Street
41
State Street
Massachusetts
$168K +$2.46K +228 +1%
VanEck Associates
42
VanEck Associates
New York
$166K +$31.8K +2,939 +22%
Invesco
43
Invesco
Georgia
$150K – – –
GF
44
Gabelli Funds
New York
$144K – – –
ARTA
45
A.R.T. Advisors
New York
$110K -$28.6K -2,650 -20%
Bank of America
46
Bank of America
North Carolina
$77K -$65.9K -6,100 -45%
FMT
47
First Mercantile Trust
Tennessee
$40K -$3.24K -300 -7%
ACMI
48
Amida Capital Management II
New York
$34K +$35.7K +3,300 New
U
49
UBS
Switzerland
$27K +$292 +27 +1%
GXMC
50
Global X Management Company
New York
$21K +$21.5K +1,991 New
1
2
3 4

ELOS Hedge Fund Activity: Q2 2014 in Review

61 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q2 2014, worth a combined $278M — down 16% from $331M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ELOS and 5 opened new positions — a net loss of 10 holders — while 23 trimmed existing stakes and 15 added.

The largest buyer was North Tide Capital, adding an estimated $5.83M. The largest seller was Craig A. Drill, exiting entirely with an estimated $2.36M sold.

  • 61 institutional investors held Syneron Medical Ltd (ELOS) as of Q2 2014, down from 71 in Q1 2014.
  • Funds reported $278M of Syneron Medical Ltd stock for Q2 2014, down 16% quarter-over-quarter.
  • 5 funds opened new Syneron Medical Ltd positions in Q2 2014 and 15 closed out, a net change of -10 holders.
  • The largest Syneron Medical Ltd buyer in Q2 2014 was North Tide Capital, an estimated $5.83M added.
  • The largest Syneron Medical Ltd seller in Q2 2014 was Craig A. Drill, an estimated $2.36M sold.

Based on aggregated 13F filings for Q2 2014.